---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-007476"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-21T22:55:56.344230+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences reports Q3 2022 net loss of $0.8M; cash of $13.8M

## Summary
- Net loss for Q3 2022 was approximately $0.8 million.
- R&D expenses fell 48.9% YoY to $0.4 million, reflecting shift from XCART to DNase platform.
- G&A expenses decreased 8.7% to $863,000.
- Cash and cash equivalents were $13.8 million at quarter-end; expected to fund operations and pipeline development.
- DNase oncology platform advancing toward first-in-human study for pancreatic carcinoma.

## SEC filing metadata
- accession: 0001683168-22-007476
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316822007476/0001683168-22-007476-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316822007476/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-007476
- JSON: https://secwatch.observer/filing/0001683168-22-007476.json
- Plain text: https://secwatch.observer/filing/0001683168-22-007476.txt

## Key facts
- Earnings Releases
  Xenetic Biosciences, Inc. reported the three months ended September 30, 2022 results: net income approximately $0.8 million.
  - Period: the three months ended September 30, 2022
  - Net income: approximately $0.8 million
  - Result: reported results
  source text: Net loss for the quarter ended September 30, 2022 was approximately $0.8 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316822007476/0001683168-22-007476-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.